Maribavir vs ganciclovir
Adverse events · solid organ transplant recipients
Maribavir showed no clear difference in adverse events compared with ganciclovir (moderate certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 0.99 [0.79, 1.25]1 study · 303 participantsModerate